Newsroom | 42194 results

Sorted by: Latest

Medical Devices
-

Resumen: Los nuevos datos positivos de la válvula cardíaca aórtica sin sutura Perceval Plus de Corcym incluyen un seguimiento a siete años

MILÁN--(BUSINESS WIRE)--Corcym, una empresa de dispositivos médicos global dedicada a la cirugía cardiaca, anunció hoy que se incluyeron datos positivos a mediano plazo de un subanálisis de su válvula cardíaca aórtica sin sutura Perceval Plus como parte de su ensayo clínico MANTRA en una presentación oral realizada hoy en la reunión anual de la European Association for Cardio-Thoracic Surgery (EACTS). El comunicado en el idioma original es la versión oficial y autorizada del mismo. Esta traducc...
-

Samenvatting: Nieuwe positieve gegevens over hechtingloze aortaklep Perceval Plus van Corcym omvatten een follow-up tot zeven jaar

MILAAN--(BUSINESS WIRE)--Corcym, een wereldwijd bedrijf in medische hulpmiddelen dat zich richt op hartchirurgie, heeft vandaag bekendgemaakt dat positieve gegevens op middellange termijn, afkomstig uit een subanalyse van de klinische MANTRA-studie naar de hechtingloze aortaklep Perceval Plus, zijn gepresenteerd tijdens de jaarvergadering van de European Association for Cardio-Thoracic Surgery (EACTS). Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als...
-

Riassunto: Nuovi dati positivi sulla valvola aortica senza suture Perceval Plus di Corcym dal follow-up di 7 anni

MILANO--(BUSINESS WIRE)--Corcym, lo specialista globale dei dispositivi medici cardiochirurgici, oggi ha annunciato la presentazione dei dati positivi a medio termine di una sottoanalisi della sua valvola aortica senza suture Perceval Plus, parte dello studio clinico MANTRA, nel corso della presentazione orale odierna al congresso annuale della European Association for Cardio-Thoracic Surgery (EACTS). Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione uffi...
-

Les nouvelles données positives concernant la valve aortique sans suture Perceval Plus de Corcym portent sur une période de suivi allant jusqu’à 7 ans

MILAN--(BUSINESS WIRE)--Corcym, une société d’envergure mondiale spécialisée dans les dispositifs médicaux destinés à la chirurgie cardiaque, a annoncé aujourd’hui que les résultats positifs à moyen terme issus d’une sous-analyse de sa valve aortique sans suture Perceval Plus, réalisée dans le cadre de son essai clinique MANTRA, avaient fait aujourd’hui l’objet d’une présentation orale à l’occasion du congrès annuel de l’European Association for Cardio-Thoracic Surgery (EACTS). Cette étude, qui...
-

Neue positive Daten zu Corcyms nahtloser Aortenherzklappe „Perceval Plus“ umfassen eine Nachbeobachtungszeit von bis zu 7 Jahren

MAILAND--(BUSINESS WIRE)--Corcym, ein weltweit tätiges Medizintechnikunternehmen mit Schwerpunkt auf Herzchirurgie, gab heute bekannt, dass positive Zwischenergebnisse aus einer Subanalyse seiner nahtlosen Aortenherzklappe „Perceval Plus“ im Rahmen der klinischen Studie „MANTRA“ heute in einem Vortrag auf der Jahrestagung der European Association for Cardio-Thoracic Surgery (EACTS) vorgestellt wurden. Die Studie ist die längste verfügbare Nachbeobachtungsstudie zu Perceval Plus und der FREE-Gew...
-

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to two new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were appr...
-

Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up

MILAN--(BUSINESS WIRE)--Corcym's Perceval Plus sutureless aortic heart valve shows excellent durability, safety and quality of life at up to 7 years at EACTS meeting....
-

Carrot Announces Agreement to Acquire GreenMan InSightVR, Expanding Eye Care’s Leading VR Diagnostics Platform Into Vision Simulation

BROOKLYN, New York--(BUSINESS WIRE)--Carrot (formerly Virtual Field), the most widely used VR testing and diagnostic platform in eye care, today announced an agreement to acquire GreenMan Vision, Inc., the company behind InSightVR. The deal will add intraocular lens (IOL) simulation for cataract surgery to the Carrot Platform and expand Carrot from vision diagnostics into vision simulation. “For more than 40 years, patients have dreaded the visual field test,” said Jeremy Barlow, CEO of Carrot....
-

Chai Discovery Announces Collaboration with GSK Following Successful Wet-Lab Evaluation

SAN FRANCISCO--(BUSINESS WIRE)--Chai Discovery, the AI company building a computer-aided design suite for molecules, today announced a collaboration with GSK....
-

Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call...